TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company’s Runway into Late 2027/Early 2028
April 7, 2026
Biotechnology
-
-
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
April 7, 2026
-
Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing
April 6, 2026
-
Quantum-Si Announces the Start of the Proteus(TM) Roadshow
April 6, 2026
-
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
April 3, 2026
-
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
April 3, 2026
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
April 2, 2026
-
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
-
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
April 2, 2026
-
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
April 2, 2026
-
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
April 2, 2026
-
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
April 2, 2026
-
Oncolytics Biotech® Completes Domicile Change to the United States
April 1, 2026
-
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
March 31, 2026
-
Dominari 2025 Revenue Surges 487% in 2025, Balance Sheet Strengthens Significantly
March 31, 2026
-
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
March 30, 2026